JB Pharma initiates #Heart2HeartChallengeIndia
Aims to spread awareness about heart health amongst the masses
Global Pharma | 22/09/2022 | By Sudeep Soparkar | 833
Cellistic acquires Celyad Oncology GMP cell therapy manufacturing operations
Cellistic will invest substantial capital into the newly acquired 11,000- sq ft facility
<br />
Global Pharma | 21/09/2022 | By Sudeep Soparkar | 541
Merck to invest $132 million in MilliporeSigma in France
The investment will create more than 800 jobs by the end of 2028
Global Pharma | 15/09/2022 | By Sudeep Soparkar | 1182
Bota Bio collaborates with Medichem
The collaboration will increase sustainability while reducing the costs of API manufacturing
Global Pharma | 06/09/2022 | By Sudeep Soparkar | 1077
ProVac reaches its 25-year milestone in the Irish vacuum equipment market
A leader in vacuum solutions, throughout the 32 counties of Ireland, reaches a quarter of a century in business and celebrates a prosperous future. Founded in 1997, the Wexford based company, ProVac Ltd, provide a level of support for customers' vacuum pumps and systems that was previously unavailable in the region.
Global Pharma | 02/09/2022 | By Sudeep Soparkar | 713
Merck & Co to add 100 new jobs as part of Irish expansion
The company begins construction of a new facility at the site that will be focussed on its oncology biologics
<br />
Global Pharma | 29/08/2022 | By Sudeep Soparkar | 905
Strides Pharma Global bags US FDA approval for generic naproxen sodium softgel capsules
The product will be manufactured at the company's Bengaluru facility<br />
Global Pharma | 22/08/2022 | By Sudeep Soparkar | 814
Glenmark, Strides Pharma, Cipla recalls products in US
The products were recalled due to manufacturing issues
Global Pharma | 22/08/2022 | By Sudeep Soparkar | 1256
India's pharma exports rise by 8% in Q1 to $6.26 Bn
Pharma exports are expected to return to normal once the Russia-Ukraine war improves
Global Pharma | 18/08/2022 | By Sudeep Soparkar | 759
PCI Pharma to expand operations at Welsh site
The manufacturing operations will be upgraded as part of the company’s push into targeted oncology therapies
Global Pharma | 12/08/2022 | By Sudeep Soparkar | 939
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy